Drug intelligence / Profile preview

isopropylmethylphenol + fluoride

Development stage: Unknown
Modality: Small Molecules
Administration: Topical, Oral

Overview

Isopropylmethylphenol (IPMP) + fluoride is a combination used primarily in oral care products such as toothpastes and mouthwashes. Isopropylmethylphenol (IPMP) acts as an antibacterial agent, inhibiting the growth of a wide range of bacteria including *Streptococcus mutans*, which are implicated in dental plaque and caries formation. Fluoride, commonly present as sodium fluoride or other salts, strengthens tooth enamel by promoting remineralization and making teeth more resistant to acid produced by bacteria. The combination aims to both reduce bacterial load and enhance enamel resistance to decay for improved oral health[1][2][5].

Other names: IPMP + fluorideisopropyl methylphenol + fluoride

Targets

FAP (Fibroblast activation protein alpha)

Beyond the preview

Go deeper on isopropylmethylphenol + fluoride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on isopropylmethylphenol + fluoride.

Explore the full profile